MoneyWorks4Me

Piramal Pharma gets EIR for manufacturing facility in USA

09 Nov 2023 Evaluate

Piramal Pharma has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the manufacturing facility located at Bethlehem, USA and the inspection has now been successfully closed by the USFDA.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.


Peers
Company Name CMP
Sun Pharma. Inds. 1846.30
Dr. Reddys Labs. 1221.50
Cipla 1392.30
Lupin 2071.65
Zydus Lifesciences 1213.10
View more..